Core Viewpoint - China Medical Group (08225) has announced a new framework service agreement with Mr. Guo Xia, extending the term of the 2022 service agreement until December 10, 2025, and setting annual caps for the years ending December 31, 2025, 2026, and 2027 [1] Group 1 - The new framework service agreement is intended to renew the previous service agreement established in 2022 [1] - The company has appointed Hongbo Capital Limited as an independent financial advisor to provide advice to the independent board committee and independent shareholders regarding the new framework service agreement and annual caps [1] - Hongbo Capital Limited is a licensed corporation authorized to conduct regulated activities under the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) [1]
中国医疗集团(08225):浤博资本获任为独立财务顾问